Skip to main content
Fig. 1 | Health Economics Review

Fig. 1

From: Quality of life and cost consequence of delays in endovascular treatment for acute ischemic stroke in China

Fig. 1

Model Structure Acute ischemic stroke patients in China entered the model-based analysis (A), received either EVT or non-EVT treatment based on the eligibility rate at different treatment initiation time windows (B), and entered a health state based on the modified Rankin Scale (mRS) score at 90 days (C). During each one-year cycle of Markov model, patients remained in the same health state, experienced a recurrent stroke, or died from either age-specific mortality or excess mortality due to stroke (D)

Back to article page